ENGINEERED TARGET SPECIFIC NUCLEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230067653A1
SERIAL NO

17848330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are engineered nucleases comprising mutations in the cleavage domain (e.g., FokI or homologue thereof) and/or DNA binding domain (zinc finger protein, TALE, single guide RNA) such that on-target specificity is increased.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INCU S A

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeKelver, Russell Brisbane, US 20 721
Krivega, Ivan Brisbane, US 3 4
Miller, Jeffrey C Brisbane, US 104 3965
Zhang, Lei Brisbane, US 2799 20393

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation